Current regulatory approaches for accessing potential COVID-19 therapies

被引：0

作者：

Vesa Halimi

Armond Daci

Simona Stojanovska

Irina Panovska-Stavridis

Milena Stevanovic

Venko Filipce

Aleksandra Grozdanova

机构：

[1] Faculty of Pharmacy,Department of Pharmacy, Faculty of Medicine

[2] University Ss. Cyril and Methodius,undefined

[3] University of Prishtina,undefined

[4] University Clinic of Hematology,undefined

[5] Medical Faculty,undefined

[6] University Ss. Cyril and Methodius,undefined

[7] University Clinic of Infection diseases and febrile conditions,undefined

[8] Medical Faculty,undefined

[9] University Ss. Cyril and Methodius,undefined

[10] University Clinic for Neurosurgery,undefined

[11] Medical Faculty,undefined

[12] University Ss. Cyril and Methodius,undefined

来源：

Journal of Pharmaceutical Policy and Practice | / 13卷

关键词：

COVID-19; Regulatory; EMA; FDA; Clinical studies; Compassionate use; Clinical practice; Off-label use; Emergency use;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective and safe to date, the best clinical choice is acquired only after consistent and fair communication and collaboration between licensed clinicians, researchers, regulatory authorities, manufacturers and patients.

引用

共 50 条

[41] The Potential Drug Interactions Between Multiple Sclerosis and COVID-19 Therapies
Goncuoglu, Cansu
Bayraktar Ekincioglu, Aygin
Tuncer, Asli
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 18 (06) : 665 - 666
[42] Host-directed therapies: a potential solution to combat COVID-19
Baindara, Piyush
Agrawal, Sonali
Mandal, Santi M.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (10) : 1117 - 1120
[43] COVID-19 and heme oxygenase: novel insight into the disease and potential therapies
Philip L. Hooper
Cell Stress and Chaperones, 2020, 25 : 707 - 710
[44] Accessing unproven interventions in the COVID-19 pandemic: discussion on the ethics of 'compassionate therapies' in times of catastrophic pandemics
Zuckerman, Shlomit
Barlavie, Yaron
Niv, Yaron
Arad, Dana
Lev, Shaul
JOURNAL OF MEDICAL ETHICS, 2022, 48 (12) : 1000 - 1005
[45] Therapies Curtailed by the COVID-19 Pandemic
Sklar, Jamie
Rapoport, Eli
Milanaik, Ruth
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2022, 43 (02): : E138 - E139
[46] An Analysis of Antioxidant Therapies for COVID-19
Holt, Alan
Davies, Adrian
ADVANCED THEORY AND SIMULATIONS, 2023, 6 (12)
[47] COVID-19 and Treatment Approaches
Ilhan, Sevil Ozger
Fincan, Gokce Sevim Ozturk
GAZI MEDICAL JOURNAL, 2020, 31 (2A): : 260 - 265
[48] Review of COVID-19 Antibody Therapies
Chen, Jiahui
Gao, Kaifu
Wang, Rui
Nguyen, Duc Duy
Wei, Guo-Wei
ANNUAL REVIEW OF BIOPHYSICS, VOL 50, 2021, 2021, 50 : 1 - 30
[49] Current challenges in different approaches to control COVID-19: a comprehensive review
Simran Giri
Sanjukta Sen
Rohan Singh
Paramita Paul
Ranabir Sahu
Gouranga Nandi
Tarun Kumar Dua
Bulletin of the National Research Centre, 46 (1)
[50] COVID-19 therapies and vaccine landscape
不详
NATURE MATERIALS, 2020, 19 (08) : 809 - 809

← 1 2 3 4 5 →